Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.
[BACKGROUND] Paraneoplastic glomerular diseases are triggered by substances secreted by tumor cells, such as tumor antigens, rather than direct tumor invasion.
APA
Royal V, Leung N, et al. (2026). Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.. American journal of nephrology, 57(2), 180-192. https://doi.org/10.1159/000546050
MLA
Royal V, et al.. "Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights.." American journal of nephrology, vol. 57, no. 2, 2026, pp. 180-192.
PMID
40267904
Abstract
[BACKGROUND] Paraneoplastic glomerular diseases are triggered by substances secreted by tumor cells, such as tumor antigens, rather than direct tumor invasion.
[SUMMARY] These conditions frequently manifest as glomerular disorders, particularly in the elderly, with membranous nephropathy being the most observed lesion. They often present with proteinuria, hematuria, and/or varying levels of kidney dysfunction. In some cases, the initial presentation may precede the diagnosis of malignancy and can be indistinguishable from the idiopathic glomerulopathies, requiring a high level of clinical suspicion to accurately identify a paraneoplastic origin. Although the exact pathophysiologic mechanisms underlying paraneoplastic glomerulopathy are not fully understood, they are thought to involve an immune-mediated response to tumor antigens in most cases.
[KEY MESSAGE] Recognizing paraneoplastic glomerulopathies is of significant clinical importance as their management is distinct and has substantial implications for the treatment of the associated malignancy.
[SUMMARY] These conditions frequently manifest as glomerular disorders, particularly in the elderly, with membranous nephropathy being the most observed lesion. They often present with proteinuria, hematuria, and/or varying levels of kidney dysfunction. In some cases, the initial presentation may precede the diagnosis of malignancy and can be indistinguishable from the idiopathic glomerulopathies, requiring a high level of clinical suspicion to accurately identify a paraneoplastic origin. Although the exact pathophysiologic mechanisms underlying paraneoplastic glomerulopathy are not fully understood, they are thought to involve an immune-mediated response to tumor antigens in most cases.
[KEY MESSAGE] Recognizing paraneoplastic glomerulopathies is of significant clinical importance as their management is distinct and has substantial implications for the treatment of the associated malignancy.
MeSH Terms
Humans; Paraneoplastic Syndromes; Glomerulonephritis, Membranous; Kidney Glomerulus; Antigens, Neoplasm; Glomerulonephritis